Physician profile
William K Woods
NPI 1275561011
$3,280.44
in general payments reported to CMS, 2019-2025
25 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,508 · 2020: $12.64 · 2021: $25.11 · 2022: $773 · 2023: $544 · 2024: $201 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $961.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $627.43 | 2019-2025 | Imfinzi, Tagrisso |
| Varian Medical Systems, INC. | $541.41 | 2019 | |
| Amgen INC. | $250.00 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $228.70 | 2022 | |
| Tactile Systems Technology INC | $171.50 | 2019-2025 | Nimbl, Flexitouch Plus |
| Novocure INC. | $155.23 | 2022-2023 | Optune |
| Regeneron Healthcare Solutions, INC. | $145.17 | 2022-2024 | Libtayo |
| Genentech USA, INC. | $125.00 | 2019 | |
| Lilly USA, LLC | $125.00 | 2023 | Verzenio |
| Exelixis INC. | $124.85 | 2022 | |
| Eisai INC. | $124.10 | 2023 | |
| Genzyme Corporation | $120.25 | 2019 | |
| Janssen Biotech, INC. | $115.60 | 2019 | |
| Progenics Pharmaceuticals, INC. | $100.00 | 2022 | |
| Pinnacle Biologics, INC | $81.37 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $55.10 | 2022-2025 | Datroway, Enhertu |
| Reflexion Medical, INC. | $38.96 | 2023 | Reflexion Medical Radiotherapy System |
| Myriad Genetic Laboratories, INC. | $25.11 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.16 | 2024 | |
| Boston Scientific Corporation | $23.44 | 2025 | Spaceoar System |
| Servier Pharmaceuticals LLC | $19.40 | 2023 | |
| Puma Biotechnology, INC. | $18.48 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $15.48 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.64 | 2020 | |
| Pfizer INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.